• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症防治进展的衡量。癌症防治进展衡量评估外部委员会。

Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.

出版信息

J Natl Cancer Inst. 1990 May 16;82(10):825-35.

PMID:2332901
Abstract

The questions of the extent of progress against cancer and how to measure it have stimulated attention among scientists and in Congress. In this presentation, we summarize a report requested by the Senate Appropriations Committee to address the adequacy of the existing measures of progress against cancer. The report was prepared by an extramural committee convened by the National Cancer Institute at the request of Congress. It includes extensive findings and recommendations on the existing measures of progress against cancer, the systems used to develop the data reported through the measures, the frequency and content of reports addressing progress, and the need for analytic research on this topic. Although the Extramural Committee To Assess Measures of Progress Against Cancer found the measures and systems to be generally adequate, they also found that modification or expansion of the information base is needed in many areas.

摘要

癌症防治进展的程度以及如何衡量这一进展的问题,已引起科学家和美国国会的关注。在本报告中,我们总结了一份由参议院拨款委员会要求撰写的报告,该报告旨在探讨现有癌症防治进展衡量指标的充分性。这份报告是应国会要求,由美国国立癌症研究所召集的一个外部委员会编写的。报告包含了关于现有癌症防治进展衡量指标、用于通过这些指标报告数据的系统、汇报进展情况报告的频率和内容,以及对该主题进行分析研究的必要性等方面的广泛调查结果和建议。尽管评估癌症防治进展衡量指标外部委员会发现这些指标和系统总体上是充分的,但他们也发现许多领域需要修改或扩展信息库。

相似文献

1
Measurement of progress against cancer. Extramural Committee to Assess Measures of Progress Against Cancer.癌症防治进展的衡量。癌症防治进展衡量评估外部委员会。
J Natl Cancer Inst. 1990 May 16;82(10):825-35.
2
Use of cancer performance measures in population health: a macro-level perspective.癌症绩效指标在人群健康中的应用:宏观层面的视角
J Natl Cancer Inst Monogr. 2004(33):142-54. doi: 10.1093/jncimonographs/lgh020.
3
A national framework for cancer surveillance in the United States.美国癌症监测国家框架。
Cancer Causes Control. 2005 Mar;16(2):151-70. doi: 10.1007/s10552-004-3487-5.
4
Patient-reported outcomes in cancer: a review of recent research and policy initiatives.癌症患者报告的结局:近期研究与政策举措综述
CA Cancer J Clin. 2007 Sep-Oct;57(5):278-300. doi: 10.3322/CA.57.5.278.
5
Implementing and using quality measures for children's health care: perspectives on the state of the practice.实施和使用儿童保健质量指标:实践现状透视
Pediatrics. 2004 Jan;113(1 Pt 2):217-27.
6
Five strategies for accelerating the war on cancer in an era of budget deficits.在预算赤字时代加速抗癌之战的五项策略。
Oncologist. 2009 Feb;14(2):110-6. doi: 10.1634/theoncologist.2008-0270. Epub 2009 Jan 15.
7
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
8
Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.预防性卵巢切除术:降低美国上皮性卵巢癌死亡率。一场持续的争论。
Oncologist. 1996;1(5):326-330.
9
Health-related quality of life and symptom management research sponsored by the National Cancer Institute.由美国国立癌症研究所资助的与健康相关的生活质量和症状管理研究。
J Clin Oncol. 2007 Nov 10;25(32):5128-32. doi: 10.1200/JCO.2007.12.6672.
10
Procedures and methods of benefit assessments for medicines in Germany.德国药品效益评估的程序和方法。
Eur J Health Econ. 2008 Nov;9 Suppl 1:5-29. doi: 10.1007/s10198-008-0122-5.

引用本文的文献

1
ESMO/ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2023.ESMO/ASCO 2023 年全球医学肿瘤学课程推荐
JCO Glob Oncol. 2023 Sep;9:e2300277. doi: 10.1200/GO.23.00277.
2
Deceptive measures of progress in the NHS long-term plan for cancer: case-based vs. population-based measures.NHS 癌症长期计划中进展的欺骗性衡量指标:基于病例的衡量指标与基于人群的衡量指标。
Br J Cancer. 2023 Jul;129(1):3-7. doi: 10.1038/s41416-023-02308-9. Epub 2023 Jun 17.
3
Cancer survival in the United States 2007-2016: Results from the National Program of Cancer Registries.
美国 2007-2016 年癌症生存状况:国家癌症登记计划的结果。
PLoS One. 2023 May 11;18(5):e0284051. doi: 10.1371/journal.pone.0284051. eCollection 2023.
4
Analysis of Trends in Mortality in Patients with Lymphoepithelial Carcinoma of the Head and Neck.头颈部淋巴上皮癌患者死亡率趋势分析
Int J Gen Med. 2021 Sep 29;14:6245-6250. doi: 10.2147/IJGM.S299145. eCollection 2021.
5
All-Cause Mortality Risk in National Prostate Cancer Cohort: An Impact of Population-Based Prostate Cancer Screening.国家前列腺癌队列中的全因死亡风险:基于人群的前列腺癌筛查的影响。
J Clin Med. 2021 Jun 1;10(11):2459. doi: 10.3390/jcm10112459.
6
Cancer outcomes research-a European challenge: measures of the cancer burden.癌症结局研究——欧洲的挑战:癌症负担的衡量指标。
Mol Oncol. 2021 Dec;15(12):3225-3241. doi: 10.1002/1878-0261.13012. Epub 2021 Jun 22.
7
Annual report to the nation on the status of cancer, part II: Progress toward Healthy People 2020 objectives for 4 common cancers.国家癌症报告:第二部分——4 种常见癌症实现 2020 年健康目标的进展。
Cancer. 2020 May 15;126(10):2250-2266. doi: 10.1002/cncr.32801. Epub 2020 Mar 12.
8
[Not Available].[无可用内容]。
Can Fam Physician. 2018 Mar;64(3):186-191.
9
Understanding and communicating risk: Measures of outcome and the magnitude of benefits and harms.理解与传达风险:结果指标以及益处与危害的程度
Can Fam Physician. 2018 Mar;64(3):181-185.
10
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.《1975 - 2014年美国癌症现状年度报告:聚焦生存率》
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx030.